Page 3 - Religare

Religare Finvest debt recast at final stages; NBFC to reboot in January

The company has been in financial distress due to alleged misappropriation of funds by erstwhile promoters Shivinder Singh and his brother Malvinder Singh

Ajit Mishra is bullish on Amara Raja, Cummins & PFC. Check why

Amara Raja Batteries has been trading with a corrective bias for the last eight months and recently tested the major support zone around Rs 690 levels

Street signs: New issues command attractive GMP, Religare stocks & more

The price band for Clean Science IPO is Rs 880-990 per share, while that for GR Infra is Rs 828 to 837 per share

REL to invest over Rs 100 cr in broking, housing finance business

REL has four key businesses Religare Finvest Limited (RFL) for SME finance, Care Health Insurance Limited (CHIL) - health insurance, Religare Broking Ltd (RBL) and Religare Housing Development Finance

Ajit Mishra of Religare Broking likes Muthoot Fin, IGL. Time to buy & hold

IGL has been consolidating in a range for the last three months while holding firmly above the support zone of the long-term moving averages

Top trading ideas by Ajit Mishra: Buy Asian Paints, IDFC First Bank

The overall chart pattern of Asian Paints indicates that the prevailing momentum is likely to continue

Trading calls by Ajit Mishra of Religare Broking: Buy HDFC Bank, M&M

HDFC Bank has also rebounded sharply and surpassed the resistance zone of moving averages ribbon on the daily chart

Top trading calls by Ajit Mishra: Buy Berger Paints, Havells India

Havells' stock is currently trading around the support zone of medium-term moving average (100 EMA) on the daily chart and indications are in the favor of a strong surge in near future

Weekly stock picks by Ajit Mishra of Religare Broking: Buy Dabur, HPCL

In line with other oil marketing stocks, the stock price of Hindustan Petroleum has been witnessing gradual recovery for the last two months

HC stays trial court order to Religare ex-CMD to surrender in two days

The high court also issued notice to the Enforcement Directorate (ED) and sought its stand on the appeal by December 17

Weekly stock suggestions by Religare Broking: Buy TVS Motors, Sun Pharma

Traders shouldn't miss this buying opportunity in Sun Pharmaceutical share and should create fresh longs

Bank Employees' Association wants LVB to be merged with a PSU bank

RBI's role should be thoroughly probed, says AIBEA

Religare case: Delhi court dismisses bail plea of ex-CEO Maninder Singh

Additional Sessions Judge Sandeep Yadav dismissed the bail plea of Singh, arrested on October 27, considering the severity and seriousness of the crime allegedly committed by him.

Weekly stock picks by Religare Broking: Buy Bharat Forge, IndusInd Bank

Among the private banking names, IndusInd Bank has been trading in a congestion zone and its chart pattern is showing the potential of a breakout in near future

Religare Health Insurance re-brands as Care Health Insurance

Health insurance provider Religare Health Insurance has re-christened itself as Care Health Insurance.

Stock calls by Ajit Mishra of Religare Broking: Buy Tata Chem, SBI Card

Tata Chem made an equally sharp reversal after the vertical decline in March 2020 and has made a new record high at Rs 345.90 in August

Religare Health Insurance rebrands itself as Care Health Insurance

Religare Health Insurance on Tuesday said it has re-branded itself as Care Health Insurance.

Stock picks by Ajit Mishra of Religare Broking: Buy Britannia Ind, Dabur

After a sharp dip in March 2020, Britannia Industries has recovered almost vertically and made a new record high at Rs 4,010 in July 2020

Religare fraud case: SC seeks Shivinder Singh's response on ED's plea

SC has sought a response from former Fortis Healthcare promoter Shivinder Singh on a plea filed by ED against the Delhi HC order granting him bail in the Religare Finvest money laundering case

These stocks from Ashish Kacholia's portfolio gained over 100% since April

Of the 16 mid and smallcap companies, where Kacholia held over 1% stake, 13 have outperformed the market during the current financial year